Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates
Kremer JM, Lawrence DA, Petrillo GF, Litts LL, Mullaly PM, Rynes RI, Stocker RP, Parhami N, Greenstein NS, Fuchs BR
Arthritis and rheumatism · 121 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 1995-08-01 · Arthritis Rheum · vol. 38 · número 8 · págs. 1107–1114
- Editorial
- Wiley
- Citado
- 259 citas · más que el 98% de estudios similares · 7.6× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 36 trabajos
- Acceso
- De pago
- Áreas de investigación
- Fatty Acid Research and Health · Rheumatoid Arthritis Research and Therapies · Natural Compounds in Disease Treatment
- Palabras clave
- fish oil supplementation, omega-3 fatty acids, diclofenac, NSAID discontinuation, cytokines, IL-1β, TNF-α, interleukin-6, interleukin-8, interleukin-2, tender joint count, morning stiffness, pain, dietary supplementation, immune response
- MeSH
- humans, arthritis, rheumatoid, diclofenac, fatty acids, omega-3, fish oils, anti-inflammatory agents, non-steroidal, cytokines, placebos, drug administration schedule, data interpretation, statistical, time factors, middle aged, female, male
14 autores
- Joel M. Kremer🇺🇸 · autor de correspondenciaAlbany Medical College; Albany Medical Center Hospital
- David A. Lawrence🇺🇸Albany Medical College
- Gayle F. Petrillo🇺🇸Albany Medical College
- Laura L. Litts🇺🇸Albany Medical College
- Patrick M. Mullaly🇺🇸Albany Medical College
- Richard I. Rynes🇺🇸Albany Medical College
- Ralph P. Stocker🇺🇸Albany Medical College
- Nourollah Parhami🇺🇸Albany Medical College
- Neal S. Greenstein🇺🇸Albany Medical College
- Betsy R. Fuchs🇺🇸Albany Medical College
- Anupum Mathur🇺🇸Albany Medical College
- Dwight Rienzi. Robinson🇺🇸Massachusetts General Hospital
- Richard I. Sperling🇺🇸Brigham and Women's Hospital; Harvard University
- Jean Bigaouette
Resumen
El texto original del estudio, en el idioma en que se publicó.
Objective
To determine the following: 1) whether dietary supplementation with fish oil will allow the discontinuation of nonsteroidal antiinflammatory drugs (NSAIDs) in patients with rheumatoid arthritis (RA); 2) the clinical efficacy of high-dose dietary omega 3 fatty acid fish oil supplementation in RA patients; and 3) the effect of fish oil supplements on the production of multiple cytokines in this population.
Methods
Sixty-six RA patients entered a double-blind, placebo-controlled, prospective study of fish oil supplementation while taking diclofenac (75 mg twice a day). Patients took either 130 mg/kg/day of omega 3 fatty acids or 9 capsules/day of corn oil. Placebo diclofenac was substituted at week 18 or 22, and fish oil supplements were continued for 8 weeks (to week 26 or 30). Serum levels of interleukin-1 beta (IL-1 beta), IL-2, IL-6, and IL-8 and tumor necrosis factor alpha were measured by enzyme-linked immunosorbent assay at baseline and during the study.
Results
In the group taking fish oil, there were significant decreases from baseline in the mean (+/- SEM) number of tender joints (5.3 +/- 0.835; P < 0.0001), duration of morning stiffness (-67.7 +/- 23.3 minutes; P = 0.008), physician's and patient's evaluation of global arthritis activity (-0.33 +/- 0.13; P = 0.017 and -0.38 +/- 0.17; P = 0.036, respectively), and physician's evaluation of pain (-0.38 +/- 0.12; P = 0.004). In patients taking corn oil, no clinical parameters improved from baseline. The decrease in the number of tender joints remained significant 8 weeks after discontinuing diclofenac in patients taking fish oil (-7.8 +/- 2.6; P = 0.011) and the decrease in the number of tender joints at this time was significant compared with that in patients receiving corn oil (P = 0.043). IL-1 beta decreased significantly from baseline through weeks 18 and 22 in patients consuming fish oil (-7.7 +/- 3.1; P = 0.026).
Conclusion
Patients taking dietary supplements of fish oil exhibit improvements in clinical parameters of disease activity from baseline, including the number of tender joints, and these improvements are associated with significant decreases in levels of IL-1 beta from baseline. Some patients who take fish oil are able to discontinue NSAIDs without experiencing a disease flare.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.